William Reed Little - 08 May 2024 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role
Executive Vice President, Corporate Development & Strategy
Signature
/s/ Matthew R. Schob, Attorney-in-Fact
Issuer symbol
OBIO
Transactions as of
08 May 2024
Net transactions value
$0
Form type
4
Filing time
10 May 2024, 17:18:51 UTC
Previous filing
24 Jul 2023
Next filing
03 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OBIO Common Stock, par value $0.0001 per share ("Common Stock") Award $0 +53,333 +21% $0.000000 303,859 08 May 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest as follows: (i) 8,000 RSUs will vest on of May 22, 2025, and (ii) the remaining 45,333 RSUs will vest in equal installments on August 22, 2025, November 22, 2025, December 24, 2025, May 22, 2026, August 22, 2026, November 22, 2026, March 25, 2027, May 22, 2027, August 22, 2027, November 22, 2027, March 25, 2028 and May 22, 2028, subject to the Reporting Person's continuous service through such dates.

Remarks:

Executive Vice President, Corporate Development & Strategy